Yun Shi is a notable inventor based in Newbury Park, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of etelcalcetide. Her work has implications for the treatment of various medical conditions, showcasing her innovative spirit and dedication to advancing healthcare.

Latest Patents

Yun Shi holds a patent for a "Solution phase method for preparing etelcalcetide." This patent focuses on solution phase fragment coupling methods for preparing etelcalcetide and its pharmaceutically acceptable salts. This innovation is crucial for enhancing the efficacy and safety of the drug.

Career Highlights

Yun Shi is currently employed at Amgen Inc., a leading biotechnology company known for its commitment to developing innovative therapies. Her role at Amgen allows her to work on cutting-edge research and contribute to the advancement of medical science.

Collaborations

Yun Shi collaborates with talented professionals in her field, including Kevin Crossley and Aleksander Swietlow. These collaborations foster a creative environment that enhances the development of new ideas and solutions.

Conclusion

Yun Shi's contributions to the pharmaceutical industry through her innovative patent and work at Amgen Inc. highlight her as a key figure in advancing medical treatments. Her dedication to research and collaboration continues to inspire progress in healthcare.

Profile summary based on public USPTO records.